Israel’s Medi-Tate (reported here previously) has been acquired by Japanese medical corporation Olympus for $300 million. Olympus invested in Medi-Tate in 2018 and has been distributing Medi-Tate’s solutions for Benign Prostatic Hyperplasia (BPH).
https://jewishbusinessnews.com/2021/02/28/israels-medi-tate-bought-by-olympus-for-300-million/
https://www.calcalistech.com/ctech/articles/0,7340,L-3895672,00.html